Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
IMVT
#1121
Immunovant, Inc. Common Stock
27.730
0
+3.28%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+3.28%
Monthly Change
+3.47%
6 month change
+44.35%
Cambio anual
+44.35%
Cierres anteriores
26.850
0
Open
27.730
0
Bid
Ask
Low
27.730
0
High
27.730
0
Volumen
113
Markets
Acciones
Atención Sanitaria
IMVT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
Immunovant stock hits 52-week high at 28.32 USD
Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?
Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus
Il titolo di Immunovant raggiunge il massimo storico a 27,87 USD
Immunovant stock hits all-time high at 27.87 USD
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript
Roivant Sciences Q4 2025: dati positivi su brepocitinib guidano slancio pipeline
Le azioni di Immunovant salgono del 7% con perdite del Q3 ridotte, superando le stime
Immunovant shares jump 7% as Q3 loss narrows, beats estimates
Philip Morris, Biogen, Telenor, and more set to report earnings Friday